NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Terns Pharmaceuticals Inc (NASDAQ: TERN)

 
TERN Technical Analysis
5
As on 9th Jun 2023 TERN STOCK Price closed @ 11.98 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 3.93 & Strong Buy for SHORT-TERM with Stoploss of 5.12 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

TERNSTOCK Price

Open 12.50 Change Price %
High 12.50 1 Day -0.50 -4.01
Low 11.93 1 Week 1.42 13.45
Close 11.98 1 Month -0.71 -5.59
Volume 395330 1 Year 6.33 112.04
52 Week High 13.29 | 52 Week Low 1.50
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
TERN
Daily Charts
TERN
Intraday Charts
Whats New @
Bazaartrend
TERN
Free Analysis
 
TERN Important Levels Intraday
RESISTANCE13.08
RESISTANCE12.73
RESISTANCE12.51
RESISTANCE12.29
SUPPORT11.67
SUPPORT11.45
SUPPORT11.23
SUPPORT10.88
 
TERN Forecast May 2024
4th UP Forecast18.59
3rd UP Forecast16.47
2nd UP Forecast15.16
1st UP Forecast13.85
1st DOWN Forecast10.11
2nd DOWN Forecast8.8
3rd DOWN Forecast7.49
4th DOWN Forecast5.37
 
TERN Weekly Forecast
4th UP Forecast14.08
3rd UP Forecast13.41
2nd UP Forecast12.99
1st UP Forecast12.57
1st DOWN Forecast11.39
2nd DOWN Forecast10.97
3rd DOWN Forecast10.55
4th DOWN Forecast9.88
 
TERN Forecast2024
4th UP Forecast36.24
3rd UP Forecast28.46
2nd UP Forecast23.65
1st UP Forecast18.84
1st DOWN Forecast5.12
2nd DOWN Forecast0.31
3rd DOWN Forecast-4.5
4th DOWN Forecast-12.28
 
 
TERN Other Details
Segment EQ
Market Capital 230447600.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
TERN Address
TERN
 
TERN Latest News
 
Your Comments and Response on Terns Pharmaceuticals Inc
 
TERN Business Profile
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and other chronic liver diseases. It develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical trial for the treatment of NASH; and TERN-201, a vascular adhesion protein-1 inhibitor that is in Phase I clinical trial for the treatment of NASH. The company also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase I clinical trial for the treatment of NASH; and GLP-1R, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to address metabolic processes involved in the pathogenesis of NASH. Terns Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Foster City, California. Address: 1065 East Hillsdale Boulevard, Foster City, CA, United States, 94404
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service